NUVIGIL

Drug Teva Pharmaceuticals USA, Inc.
Total Payments
$63,886
Transactions
37
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $28,681 7 3
2017 $35,204 30 4

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,125 12 55.0%
Travel and Lodging $15,447 16 24.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,540 1 19.6%
Food and Beverage $773.41 8 1.2%

Top Doctors Receiving Payments for NUVIGIL

Doctor Specialty Location Total Records
, MD Psychiatry Madison, WI $26,335 5
, MD Pediatrics Providence, RI $15,785 14
, MD Psychiatry Philadelphia, PA $11,200 2
, MD Obstetrics & Gynecology Voorhees, NJ $8,094 11
, MD, JD Psychiatry North Wales, PA $2,325 1
, M.D Clinical Genetics (M.D.) Dallas, TX $125.01 3
, MD Hematology & Oncology Arcadia, CA $21.28 1

About NUVIGIL

NUVIGIL is a drug associated with $63,886 in payments to 7 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..

Payment data is available from 2017 to 2018. In 2018, $28,681 was paid across 7 transactions to 3 doctors.

The most common payment nature for NUVIGIL is "Consulting Fee" ($35,125, 55.0% of total).